72,000-patient study finds Ozempic improves heart and kidney health with no increased adverse events when combined with older diabetes meds.
Ozempic, a diabetes drug, may also improve heart and kidney health based on new research from Sydney's George Institute for Global Health and Royal North Shore Hospital. The study, involving 72,000 patients globally, found no increase in adverse events when combining Ozempic (semaglutide) with older diabetes medications. However, Australia's supply shortage will not be resolved this year.
July 13, 2024
4 Articles